Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: A systematic review
- PMID: 34083122
- PMCID: PMC8162904
- DOI: 10.1016/j.pcd.2021.05.011
Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: A systematic review
Abstract
Background: The Coronavirus disease 2019 (COVID-19) pandemic has led to a dramatic crisis in health care systems worldwide. These may have significant implications for the management of cardiometabolic diseases. We conducted a systematic review of published evidence to assess the indirect impact of the COVID-19 pandemic on hospitalisations for cardiovascular diseases and their management.
Methods: Studies that evaluated volume of hospitalisations for cardiometabolic conditions and their management with comparisons between the COVID-19 and pre-COVID periods were identified from MEDLINE, Embase and the reference list of relevant studies from January 2020 to 25 February 2021.
Results: We identified 103 observational studies, with most studies assessing hospitalisations for acute cardiovascular conditions such as acute coronary syndrome, ischemic strokes and heart failure. About 89% of studies reported a decline in hospitalisations during the pandemic compared to pre-pandemic times, with reductions ranging from 20.2 to 73%. Severe presentation, less utilization of cardiovascular procedures, and longer patient- and healthcare-related delays were common during the pandemic. Most studies reported shorter length of hospital stay during the pandemic than before the pandemic (1-8 vs 2-12 days) or no difference in length of stay. Most studies reported no change in in-hospital mortality among hospitalised patients.
Conclusion: Clinical care of patients for acute cardiovascular conditions, their management and outcomes have been adversely impacted by the COVID-19 pandemic. Patients should be educated via population-wide approaches on the need for timely medical contact and health systems should put strategies in place to provide timely care to patients at high risk.
Systematic review registration: PROSPERO 2021: CRD42021236102.
Keywords: Acute coronary syndrome; COVID-19; Diabetes; Hospitalisation; Impact; Stroke cardiovascular disease; Systematic review.
Copyright © 2021 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
Figures
References
-
- Wu Z., McGoogan J. Characteristics of and important lessons from the 367 coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 368 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;369 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
